• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , July 6

THE International Generic Pharmaceutical Alliance (IGPA) now has an Indian at the helm.

Mr Dilip G. Shah, Secretary General of the Indian Pharmaceutical Alliance (IPA) has become the Chairman of IGPA.

This assumes significance at a time when pharma lobbies in other developed markets set out to discredit generic drug producers, including companies from India.

Founded in 1998 by the Canadian Drug Manufacturers Association, the European Generic medicines Association and the Generic Pharmaceutical Association, USA - the objective of IGPA is to ensure access to affordable quality medicines.

The Indian Pharmaceutical Alliance (IPA) was accepted as a member of the IGPA in 2002. The IGPA represents over 500 companies involved in the generic medicines and active ingredient industry.

These companies provide a substantial part of the pharmaceutical market in the European and North American regions, besides being players in other regions such as the Middle East, Africa, Asia and Latin America.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
IMD stands by normal monsoon forecast, sees 97 pc rainfall in July

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line